Perrigo Co. PLC stock falls 1.91% during poor market session

8 articles · Updated · MarketWatch · Apr 29

Shares closed at $11.29 on Wednesday, underperforming major competitors like Johnson & Johnson, Procter & Gamble, and Abbott Laboratories.
The stock is now 60.30% below its 52-week high of $28.44 reached on July 25th, highlighting ongoing weakness.
The broader market also declined, with the S&P 500 down 0.04% and the Dow Jones falling 0.57% during the session.

With a recent analyst upgrade, has Perrigo's stock finally hit rock bottom after its steep decline?

Is Perrigo's 10% dividend a sign of value or a warning of deeper financial trouble ahead?

After a $1.3B loss, can Perrigo's new cost-cutting plan save its 'transition year' from further decline?

Perrigo lost $1.4 billion last year, so how can it afford to keep raising its dividend?

Following a massive write-down, is Perrigo preparing to sell its struggling Infant Formula business?